Clinical Limit of Detection May Represent Viable cfDNA Metric For Detection of Multiple Cancers
Data from the Circulating Cell-Free Genome Atlas on Clinical limit of detection, or cLOD, may help investigators better detect multiple cancers at earlier stages.
Communication Improvements Necessary for Understanding Aspects of Renal Cell Carcinoma
A lack of understanding, communication, and more was expressed among both patients and caregivers regarding a subtype of kidney cancer.
Pralsetinib Shows Durable Activity in Chinese Patient With RET Fusion+ NSCLC
Data from the ARROW study demonstrated safety and efficacy of pralsetinib in a cohort of Chinese patients with RET fusion–positive non–small cell lung cancer.
Patients With MPNs May Require More Cardiovascular Risk Management
Retrospective data presented at 2021 EHA revealed potential treatment gaps in the management of patients with myeloproliferative neoplasms.
Adding Lifileucel to Pembrolizumab for Immunotherapy-Naïve Melanoma Improved Responses
A higher overall response rate was noted with lifileucel and pembrolizumab versus pembrolizumab alone in patients with checkpoint inhibitor–naïve advanced melanoma, according to phase 2 trial results that were reported at the 2021 ASCO Annual Meeting.
High Rate of Response Noted in MCL and CLL With Cirmtuzumab Plus Ibrutinib
Most patients with either mantle cell lymphoma or chronic lymphocytic leukemia who were treated in a phase 1/2 trial had a response to therapy with the combination of cirmtuzumab plus ibrutinib.
Patients With Advanced CRC May Experience Survival Benefit With Lenvatinib Plus Pembrolizumab Combo
Phase 2 data presented at the 2021 ASCO Annual Meeting indicate that more than half of patients with previously treated advanced colorectal cancer who were treated with pembrolizumab plus lenvatinib were alive at 6 months.
Adherence to Oral Chemotherapy Regimens May Improve With Assistance From Smartphone Mobile Apps
Better adherence to oral chemotherapy was seen in patients who used a smartphone mobile app, according to a presentation at the Oncology Nursing Society’s 46th Annual Congress.
2 Clarke Drive Cranbury, NJ 08512